Press release
September 24, 2026
Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 27th Annual Neuromuscular Study Group Scientific Meeting
Sarepta Therapeutics, Inc. (SRPT)
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Sep. 24, 2026-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present new data at the 27 th Annual Neuromuscular Study Group (NMSG) Scientific Meeting, taking place Sept.